Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

OriCAR-017 is a second-generation, autologous, GPRC5D-directed CAR T-cell therapy that improves the expansion and durability of CAR T-cells...

Toby Eyre, MBChB (Hons), DipMedEd, MRCP (UK), FRCPath (UK), MD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses...

The study met its primary endpoint, elucidating the adverse events associated with golidocitinib in patients with R/R PTCL. Preliminary data has demonstrated a favorable...

John Gribben, MD, DSc, FRCP, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, discusses patient risk stratification in chronic...

Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, discusses advances in allogeneic CAR-T therapy for the treatment of relapsed/refractory...

Won Seog Kim, MD, PhD, Sungkyunkwan University School of Medicine, Seoul, South Korea, discusses the importance of plasma circulating...

Mashup Score:2

VJHemOnc

Insights into the DREAMM-14 trial - 1 week

Mashup Score:2

Malin Hultcrantz, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, briefly discusses the DREAMM-14 trial (NCT05064358), which...

In the IFM-2018-04 trial, the quadruplet of dara-KRd with tandem transplant was assessed in patients with NDMM eligible for transplant; Touzeau presented the results...

Nilanjan Ghosh, MD, PhD, Atrium Health Levine Cancer Institute, Charlotte, NC, briefly discusses mechanisms of resistance to immunotherapy in...